Fluidx Medical Technology, Inc.
Fluidx Medical Technology, Inc. is developing innovative embolic devices focused on ease of use, controlled delivery, and durable occlusions. GPX (oncology/distal), ULTRA (hemorrhage/proximal), and IMPASS (neurovascular) Embolic Devices are DMSO free, radiopaque, and highly controllable. Devices do not yet have marketing clearance or approval.